Recombinant Human Otoraplin (CHO-expressed) 是由 OTOR 编码的蛋白质，与 CDRAP/MIA 编码蛋白同源，在软骨的发育和维持中可能具有一定的作用。
Synonyms
rHuOTOR; Fibrocyte-derived protein; Melanoma inhibitory activity-like protein; OTOR; MIAL ; 重组人内耳纤维细胞源性蛋白 (CHO 表达)
Species
HumanSource
CHO Accession
Q9NRC9 Gene ID
56914 Molecular Weight
14-15 kDa AA Sequence
VHGIFMDRLA SKKLCADDEC VYTISLASAQ EDYNAPDCRF INVKKGQQIY VYSKLVKENG AGEFWAGSVY GDGQDEMGVV GYFPRNLVKE QRVYQEATKE VPTTDIDFFC E Appearance
Lyophilized powder. Formulation
Lyophilized after extensive dialysis against PBS. Endotoxin Level
<0.2 EU/μg, determined by LAL method. Reconstitution
Reconstitute the lyophilized recombinant Human Otoraplin (CHO-expressed) (rHuOTOR) to 100 µg/mL using ddH2O or diluted with PBS. Storage & Stability
Lyophilized recombinant Human Otoraplin (CHO-expressed) (rHuOTOR) is stored at -20°C. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer. It is recommended to freeze aliquots at -20°C or -80°C for extended storage. Shipping
Room temperature in continental US; may vary elsewhere. Background
Human Otoraplin is a protein encoded by OTOR gene, is homologous to the protein encoded by CDRAP/MIA, and may acts in cartilage development and maintenance[1]. |
